Wellgistics Health (NASDAQ:WGRX) Rating Lowered to "Sell" at Wall Street Zen

Key Points

• Wellgistics Health (NASDAQ:WGRX) has been downgraded from a "hold" to a "sell" rating by analysts at Wall Street Zen.
• The company's stock opened at $0.94 on Friday, reflecting a 1.1% decrease, with a 1-year low of $0.75 and a high of $7.04.
• Founded in 2022, Wellgistics Health operates as a holding company focused on pharmaceuticals and healthcare services, featuring a portfolio that includes a pharmacy and technology division.

Wellgistics Health (NASDAQ:WGRX - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued on Saturday.

Wellgistics Health Stock Down 1.1%

WGRX stock opened at $0.94 on Friday. The company has a current ratio of 0.36, a quick ratio of 0.15 and a debt-to-equity ratio of 1.43. Wellgistics Health has a 1-year low of $0.75 and a 1-year high of $7.04.

Wellgistics Health Company Profile

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.